ID   LIPS_HUMAN              Reviewed;        1076 AA.
AC   Q05469; Q3LRT2; Q6NSL7;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   17-APR-2007, sequence version 4.
DT   10-MAY-2017, entry version 160.
DE   RecName: Full=Hormone-sensitive lipase;
DE            Short=HSL;
DE            EC=3.1.1.79;
GN   Name=LIPE;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8506334; DOI=10.1073/pnas.90.11.4897;
RA   Langin D., Laurell H., Stenson Holst L., Belfrage P., Holm C.;
RT   "Gene organization and primary structure of human hormone-sensitive
RT   lipase: possible significance of a sequence homology with a lipase of
RT   Moraxella TA144, an antarctic bacterium.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:4897-4901(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=8812477; DOI=10.1006/geno.1996.0383;
RA   Holst L.S., Langin D., Mulder H., Laurell H., Grober J., Bergh A.,
RA   Mohrenweiser H.W., Edgren G., Holm C.;
RT   "Molecular cloning, genomic organization, and expression of a
RT   testicular isoform of hormone-sensitive lipase.";
RL   Genomics 35:441-447(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS HIS-100; HIS-127;
RP   SER-146; THR-177; VAL-194; GLN-217; ASN-497; HIS-499 AND SER-938.
RG   SeattleSNPs variation discovery resource;
RL   Submitted (AUG-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   INTERACTION WITH PTRF, AND SUBCELLULAR LOCATION.
RX   PubMed=17026959; DOI=10.1016/j.bbrc.2006.09.094;
RA   Aboulaich N., Oertegren U., Vener A.V., Stralfors P.;
RT   "Association and insulin regulated translocation of hormone-sensitive
RT   lipase with PTRF.";
RL   Biochem. Biophys. Res. Commun. 350:657-661(2006).
RN   [6]
RP   SUBCELLULAR LOCATION.
RX   PubMed=16803459; DOI=10.1111/j.1742-4658.2006.05345.x;
RA   Oertegren U., Yin L., Oest A., Karlsson H., Nystrom F.H.,
RA   Stralfors P.;
RT   "Separation and characterization of caveolae subclasses in the plasma
RT   membrane of primary adipocytes; segregation of specific proteins and
RT   functions.";
RL   FEBS J. 273:3381-3392(2006).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [8]
RP   INVOLVEMENT IN FPLD6.
RX   PubMed=24848981; DOI=10.1056/NEJMoa1315496;
RA   Albert J.S., Yerges-Armstrong L.M., Horenstein R.B., Pollin T.I.,
RA   Sreenivasan U.T., Chai S., Blaner W.S., Snitker S., O'Connell J.R.,
RA   Gong D.W., Breyer R.J., Ryan A.S., McLenithan J.C., Shuldiner A.R.,
RA   Sztalryd C., Damcott C.M.;
RT   "Null mutation in hormone-sensitive lipase gene and risk of type 2
RT   diabetes.";
RL   N. Engl. J. Med. 370:2307-2315(2014).
RN   [9]
RP   VARIANT [LARGE SCALE ANALYSIS] GLN-146.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: In adipose tissue and heart, it primarily hydrolyzes
CC       stored triglycerides to free fatty acids, while in steroidogenic
CC       tissues, it principally converts cholesteryl esters to free
CC       cholesterol for steroid hormone production.
CC   -!- CATALYTIC ACTIVITY: Diacylglycerol + H(2)O = monoacylglycerol + a
CC       carboxylate.
CC   -!- CATALYTIC ACTIVITY: Triacylglycerol + H(2)O = diacylglycerol + a
CC       carboxylate.
CC   -!- CATALYTIC ACTIVITY: Monoacylglycerol + H(2)O = glycerol + a
CC       carboxylate.
CC   -!- ENZYME REGULATION: Rapidly activated by cAMP-dependent
CC       phosphorylation under the influence of catecholamines.
CC       Dephosphorylation and inactivation are controlled by insulin.
CC   -!- PATHWAY: Glycerolipid metabolism; triacylglycerol degradation.
CC   -!- SUBUNIT: Interacts with PTRF in the adipocyte cytoplasm. Interacts
CC       with PLIN5 (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane. Membrane, caveola. Cytoplasm,
CC       cytosol. Note=Found in the high-density caveolae. Translocates to
CC       the cytoplasm from the caveolae upon insulin stimulation.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=Testicular;
CC         IsoId=Q05469-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q05469-2; Sequence=VSP_017116;
CC   -!- PTM: Phosphorylation by AMPK may block translocation to lipid
CC       droplets. {ECO:0000250}.
CC   -!- DISEASE: Lipodystrophy, familial partial, 6 (FPLD6) [MIM:615980]:
CC       A form of lipodystrophy characterized by abnormal subcutaneous fat
CC       distribution. Affected individuals have increased visceral fat,
CC       impaired lipolysis, dyslipidemia, hepatic steatosis, systemic
CC       insulin resistance, and diabetes. Some patients manifest muscular
CC       dystrophy. {ECO:0000269|PubMed:24848981}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the 'GDXG' lipolytic enzyme family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/lipe/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L11706; AAA69810.1; -; Genomic_DNA.
DR   EMBL; U40001; AAC50666.1; -; mRNA.
DR   EMBL; DQ188033; ABA03168.1; -; Genomic_DNA.
DR   EMBL; BC070041; AAH70041.1; -; mRNA.
DR   CCDS; CCDS12607.1; -. [Q05469-1]
DR   RefSeq; NP_005348.2; NM_005357.3. [Q05469-1]
DR   RefSeq; XP_005258997.1; XM_005258940.3. [Q05469-2]
DR   RefSeq; XP_006723281.1; XM_006723218.2. [Q05469-2]
DR   RefSeq; XP_016882299.1; XM_017026810.1. [Q05469-2]
DR   UniGene; Hs.656980; -.
DR   ProteinModelPortal; Q05469; -.
DR   SMR; Q05469; -.
DR   BioGrid; 110179; 7.
DR   IntAct; Q05469; 3.
DR   MINT; MINT-1370154; -.
DR   STRING; 9606.ENSP00000244289; -.
DR   BindingDB; Q05469; -.
DR   ChEMBL; CHEMBL3590; -.
DR   GuidetoPHARMACOLOGY; 2593; -.
DR   SwissLipids; SLP:000000316; -.
DR   ESTHER; human-LIPE; Hormone-sensitive_lipase_like_1.
DR   MEROPS; S09.993; -.
DR   iPTMnet; Q05469; -.
DR   PhosphoSitePlus; Q05469; -.
DR   BioMuta; LIPE; -.
DR   DMDM; 145559491; -.
DR   EPD; Q05469; -.
DR   MaxQB; Q05469; -.
DR   PaxDb; Q05469; -.
DR   PeptideAtlas; Q05469; -.
DR   PRIDE; Q05469; -.
DR   Ensembl; ENST00000244289; ENSP00000244289; ENSG00000079435. [Q05469-1]
DR   GeneID; 3991; -.
DR   KEGG; hsa:3991; -.
DR   UCSC; uc002otr.4; human. [Q05469-1]
DR   CTD; 3991; -.
DR   DisGeNET; 3991; -.
DR   GeneCards; LIPE; -.
DR   H-InvDB; HIX0040096; -.
DR   HGNC; HGNC:6621; LIPE.
DR   HPA; CAB017700; -.
DR   HPA; HPA006567; -.
DR   MalaCards; LIPE; -.
DR   MIM; 151750; gene.
DR   MIM; 615980; phenotype.
DR   neXtProt; NX_Q05469; -.
DR   OpenTargets; ENSG00000079435; -.
DR   PharmGKB; PA30393; -.
DR   eggNOG; KOG4388; Eukaryota.
DR   eggNOG; COG0657; LUCA.
DR   GeneTree; ENSGT00730000111056; -.
DR   HOGENOM; HOG000047722; -.
DR   HOVERGEN; HBG000187; -.
DR   InParanoid; Q05469; -.
DR   KO; K07188; -.
DR   OMA; FLNFTML; -.
DR   OrthoDB; EOG091G0AZN; -.
DR   PhylomeDB; Q05469; -.
DR   TreeFam; TF314423; -.
DR   BioCyc; MetaCyc:HS01328-MONOMER; -.
DR   BRENDA; 3.1.1.79; 2681.
DR   Reactome; R-HSA-163560; Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis.
DR   SABIO-RK; Q05469; -.
DR   SIGNOR; Q05469; -.
DR   UniPathway; UPA00256; -.
DR   GeneWiki; Hormone-sensitive_lipase; -.
DR   GenomeRNAi; 3991; -.
DR   PRO; PR:Q05469; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000079435; -.
DR   CleanEx; HS_LIPE; -.
DR   ExpressionAtlas; Q05469; baseline and differential.
DR   Genevisible; Q05469; HS.
DR   GO; GO:0005901; C:caveola; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005811; C:lipid particle; ISS:UniProtKB.
DR   GO; GO:0033878; F:hormone-sensitive lipase activity; IEA:UniProtKB-EC.
DR   GO; GO:0019901; F:protein kinase binding; IEA:Ensembl.
DR   GO; GO:0004806; F:triglyceride lipase activity; IEA:Ensembl.
DR   GO; GO:0008203; P:cholesterol metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0046340; P:diacylglycerol catabolic process; IEA:Ensembl.
DR   GO; GO:0016042; P:lipid catabolic process; ISS:UniProtKB.
DR   GO; GO:0042758; P:long-chain fatty acid catabolic process; IEA:Ensembl.
DR   GO; GO:0006468; P:protein phosphorylation; TAS:ProtInc.
DR   GO; GO:0019433; P:triglyceride catabolic process; IEA:UniProtKB-UniPathway.
DR   Gene3D; 3.40.50.1820; -; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR013094; AB_hydrolase_3.
DR   InterPro; IPR010468; HSL_N.
DR   InterPro; IPR002168; Lipase_GDXG_HIS_AS.
DR   InterPro; IPR033140; Lipase_GDXG_put_SER_AS.
DR   Pfam; PF07859; Abhydrolase_3; 2.
DR   Pfam; PF06350; HSL_N; 1.
DR   SUPFAM; SSF53474; SSF53474; 2.
DR   PROSITE; PS01173; LIPASE_GDXG_HIS; 1.
DR   PROSITE; PS01174; LIPASE_GDXG_SER; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Cholesterol metabolism;
KW   Complete proteome; Cytoplasm; Diabetes mellitus; Hydrolase;
KW   Lipid degradation; Lipid metabolism; Membrane; Obesity;
KW   Phosphoprotein; Polymorphism; Reference proteome; Steroid metabolism;
KW   Sterol metabolism.
FT   CHAIN         1   1076       Hormone-sensitive lipase.
FT                                /FTId=PRO_0000071547.
FT   MOTIF       651    653       Involved in the stabilization of the
FT                                negatively charged intermediate by the
FT                                formation of the oxyanion hole.
FT                                {ECO:0000250|UniProtKB:Q5NUF3}.
FT   ACT_SITE    725    725       {ECO:0000250|UniProtKB:Q8BLF1,
FT                                ECO:0000255|PROSITE-ProRule:PRU10038}.
FT   ACT_SITE    994    994       {ECO:0000250|UniProtKB:Q8BLF1}.
FT   ACT_SITE   1024   1024       {ECO:0000250|UniProtKB:Q8BLF1}.
FT   MOD_RES     853    853       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P16386}.
FT   MOD_RES     855    855       Phosphoserine; by AMPK. {ECO:0000250}.
FT   MOD_RES     897    897       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P15304}.
FT   MOD_RES     929    929       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P15304}.
FT   MOD_RES     950    950       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P15304}.
FT   MOD_RES     951    951       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P15304}.
FT   VAR_SEQ       1    301       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_017116.
FT   VARIANT     100    100       Y -> H (in dbSNP:rs16975750).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_025108.
FT   VARIANT     127    127       Q -> H (in dbSNP:rs34080774).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_025109.
FT   VARIANT     146    146       P -> Q (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036539.
FT   VARIANT     146    146       P -> S (in dbSNP:rs34348028).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_025110.
FT   VARIANT     177    177       S -> T (in dbSNP:rs16975748).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_025111.
FT   VARIANT     194    194       A -> V (in dbSNP:rs34996020).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_025112.
FT   VARIANT     217    217       R -> Q (in dbSNP:rs3745238).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_025113.
FT   VARIANT     497    497       K -> N (in dbSNP:rs35938529).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_025114.
FT   VARIANT     499    499       N -> H (in dbSNP:rs33921216).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_025115.
FT   VARIANT     938    938       R -> S (in dbSNP:rs7246232).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_025116.
FT   CONFLICT    230    230       T -> A (in Ref. 1; AAA69810, 2; AAC50666
FT                                and 3; ABA03168). {ECO:0000305}.
FT   CONFLICT    486    486       S -> Y (in Ref. 4; AAH70041).
FT                                {ECO:0000305}.
FT   CONFLICT    608    608       Y -> C (in Ref. 4; AAH70041).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1076 AA;  116598 MW;  1CC0E3880FF64D74 CRC64;
     MEPGSKSVSR SDWQPEPHQR PITPLEPGPE KTPIAQPESK TLQGSNTQQK PASNQRPLTQ
     QETPAQHDAE SQKEPRAQQK SASQEEFLAP QKPAPQQSPY IQRVLLTQQE AASQQGPGLG
     KESITQQEPA LRQRHVAQPG PGPGEPPPAQ QEAESTPAAQ AKPGAKREPS APTESTSQET
     PEQSDKQTTP VQGAKSKQGS LTELGFLTKL QELSIQRSAL EWKALSEWVT DSESESDVGS
     SSDTDSPATM GGMVAQGVKL GFKGKSGYKV MSGYSGTSPH EKTSARNHRH YQDTASRLIH
     NMDLRTMTQS LVTLAEDNIA FFSSQGPGET AQRLSGVFAG VREQALGLEP ALGRLLGVAH
     LFDLDPETPA NGYRSLVHTA RCCLAHLLHK SRYVASNRRS IFFRTSHNLA ELEAYLAALT
     QLRALVYYAQ RLLVTNRPGV LFFEGDEGLT ADFLREYVTL HKGCFYGRCL GFQFTPAIRP
     FLQTISIGLV SFGEHYKRNE TGLSVAASSL FTSGRFAIDP ELRGAEFERI TQNLDVHFWK
     AFWNITEMEV LSSLANMASA TVRVSRLLSL PPEAFEMPLT ADPTLTVTIS PPLAHTGPGP
     VLVRLISYDL REGQDSEELS SLIKSNGQRS LELWPRPQQA PRSRSLIVHF HGGGFVAQTS
     RSHEPYLKSW AQELGAPIIS IDYSLAPEAP FPRALEECFF AYCWAIKHCA LLGSTGERIC
     LAGDSAGGNL CFTVALRAAA YGVRVPDGIM AAYPATMLQP AASPSRLLSL MDPLLPLSVL
     SKCVSAYAGA KTEDHSNSDQ KALGMMGLVR RDTALLLRDF RLGASSWLNS FLELSGRKSQ
     KMSEPIAEPM RRSVSEAALA QPQGPLGTDS LKNLTLRDLS LRGNSETSSD TPEMSLSAET
     LSPSTPSDVN FLLPPEDAGE EAEAKNELSP MDRGLGVRAA FPEGFHPRRS SQGATQMPLY
     SSPIVKNPFM SPLLAPDSML KSLPPVHIVA CALDPMLDDS VMLARRLRNL GQPVTLRVVE
     DLPHGFLTLA ALCRETRQAA ELCVERIRLV LTPPAGAGPS GETGAAGVDG GCGGRH
//
